All Stories

  1. D242N, a K V 7.1 LQTS mutation uncovers a key residue for I Ks voltage dependence
  2. Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes
  3. In-Depth Study of the Interaction, Sensitivity, and Gating Modulation by PUFAs on K+ Channels; Interaction and New Targets
  4. M-channels and n-3 polyunsaturated fatty acids: role in pain and epilepsy
  5. Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease
  6. Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death
  7. A newKCNQ1mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome
  8. Pharmacological Consequences of PKC Inhibition on Kv1.5+Kvbeta1.3 Channels
  9. Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains
  10. PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels
  11. Functional Assembly of Kv7.1/Kv7.5 Channels With Emerging Properties on Vascular Muscle Physiology
  12. Modulation of Voltage-Dependent and Inward Rectifier Potassium Channels by 15-Epi-Lipoxin-A4 in Activated Murine Macrophages: Implications in Innate Immunity
  13. Modulation of Kv and Kir Currents by 15-Epi-Lipoxin-A4 in activated Macrophages. Implications for the Regulation of the Innate Immune Response
  14. Female gender: risk factor for congenital long QT-related arrhythmias
  15. Stereoselective Interactions between Local Anesthetics and Ion Channels
  16. Protein Kinase C (PKC) Activity Regulates Functional Effects of Kv 1.3 Subunit on KV1.5 Channels: IDENTIFICATION OF A CARDIAC Kv1.5 CHANNELOSOME
  17. Polyunsaturated Fatty Acids Modify the Gating of Kv Channels
  18. Effects of n−3 Polyunsaturated Fatty Acids on Cardiac Ion Channels
  19. Irvalec Inserts Into the Plasma Membrane Causing Rapid Loss of Integrity and Necrotic Cell Death in Tumor Cells
  20. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries
  21. Irvalec Inserts into the Plasma Membrane Causing Rapid Loss of Integrity and Necrotic Cell Death in Tumor Cells
  22. Celecoxib Blocks Cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) Channels. Effects on Cardiac Action Potentials
  23. Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels
  24. 439 Rapid effects of Irvalec on tumor cell integrity associated with changes in the ionic membrane conductance
  25. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels
  26. Kv1.5-Kvβ Interactions: Molecular Determinants and Pharmacological Consequences
  27. Immunomodulation of voltage-dependent K + channels in macrophages: molecular and biophysical consequences
  28. Immunomodulation of Voltage-Dependent K+ Channels in Macrophages: Molecular and Biophysical Consequences
  29. Differential Regulation Of Navß Subunits During Myogenesis
  30. Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts
  31. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation
  32. Differential regulation of Navβ subunits during myogenesis
  33. Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, α-linolenic acid
  34. Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair☆
  35. Kvβ1.3 Reduces the Degree of Stereoselective Bupivacaine Block of Kv1.5 Channels
  36. The induction of NOS2 expression by the hybrid cecropin A–melittin antibiotic peptide CA(1–8)M(1–18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation
  37.  -3 and  -6 polyunsaturated fatty acids block HERG channels
  38. Stereoselective Interactions Between Local Anesthetics and Cardiac K+ Channels
  39. Pharmacology of cardiac potassium channels
  40. Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current
  41. Pharmacological electrical remodelling in human atria induced by chronic β-blockade
  42. Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels
  43. Spironolactone and Its Main Metabolite, Canrenoic Acid, Block Human Ether-a-Go-Go-Related Gene Channels
  44. Effects of Irbesartan on Cloned Potassium Channels Involved in Human Cardiac Repolarization
  45. Stereoselective Drug-Channel Interactions
  46. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block
  47. Assembly with the Kvβ1.3 Subunit Modulates Drug Block of hKv1.5 Channels
  48. Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5)
  49. Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH
  50. Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5)
  51. Effects of a quaternary bupivacaine derivative on delayed rectifier K+ currents
  52. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac Kv1.5 channels
  53. Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5)
  54. Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line
  55. Blockade of Cardiac Potassium and Other Channels by Antihistamines
  56. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels
  57. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5
  58. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels
  59. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels
  60. Effects of Ropivacaine on a Potassium Channel (hKv1.5) Cloned from Human Ventricle
  61. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles
  62. Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2
  63. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers
  64. Electromechanical Effects of Zatebradine on Isolated Guinea Pig Cardiac Preparations
  65. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations
  66. Effects of lisinopril on cardiac contractility and ionic currents
  67. Gating of cardiac Na+ channels in excised membrane patches after modification by alpha-chymotrypsin
  68. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles
  69. Effects of lisinopril on electromechanical properties and membrane currents in guinea-pig cardiac preparations
  70. Electrophysiological Effects of the Combination of Imipramine and Desipramine in Guinea Pig Papillary Muscles
  71. New insights into the pharmacology of sodium channel blockers
  72. Electrophysiological effects of CRE-1087 in guinea-pig ventricular muscles
  73. Pharmacology of CRE-1087, A New Antiarrhythmic Drug
  74. Voltage- and Use-Dependent Modulation of Calcium Channel Current in Guinea Pig Ventricular Cells by Amiodarone and Des-Oxo-Amiodarone
  75. Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres
  76. Tonic and frequency-dependent $$\mathop {\text{V}}\limits^{\text{.}} _{{\text{max}}} $$ block induced by (S)-nafenodone, a new antidepressant drug, in guinea-pig papillary muscles
  77. Tonic and Frequency-Dependent Vmax Block Induced by Imipramine in Guinea Pig Ventricular Muscle Fibers
  78. Electrophysiologic Interactions Between Mexiletine-Quinidine and Mexiletine-Ropitoin in Guinea Pig Papillary Muscle
  79. Electrophysiologic Interactions Between Mexiletine and Propafenone in Guinea Pig Papillary Muscles
  80. Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle
  81. Tonic and Phasic Vmax Block Induced by 5-Hydroxypropafenone in Guinea Pig Ventricular Muscles
  82. Electrophysiological Effects of 5-Hydroxypropafenone on Guinea Pig Ventricular Muscle Fibres
  83. Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres
  84. Electrophysiological effects of amoxapine in untreated and in amoxapine-pretreated rat atria
  85. Negative inotropic effect of somatostatin in guinea-pig atrial fibres